A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor

Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.

We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.

We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.

Definition medical devices.

Medical Device Industry News | Latest Developments, Breakthroughs & Future Outlook

Latest News and Developments

Ellipsys Vascular Access System to Return to U.S. Market in 2026

Ellipsys Vascular Access System to Return to U.S. Market in 2026

Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial availability anticipated in mid-2026. The announcement marks the planned reintroduction of the minimally invasive technology to clinicians and patients following a period of limited market availability. The Ellipsys System, previously available...

Clinical Trials

Biotechnology News

Mergers & Acquisitions

Funding

Laverock Therapeutics

Laverock Therapeutics Raises £13.5M

Laverock Therapeutics notes the funding will enable further development of the GEiGS technology and progression of Laverock’s programs in regenerative medicine and immuno-oncology, with a focus on Type I Diabetes and solid tumor responsive T-cell and macrophage-based immune therapies, through to in vitro and in vivo validation.

Industry Expert Bylines

3 Ways to Address Healthcare Staffing Shortages and Improve Retention: By Kristi McDermott, President of Clinical Engineering, TRIMEDX

3 Ways to Address Healthcare Staffing Shortages and Improve Retention: By Kristi McDermott, President of Clinical Engineering, TRIMEDX

McDermott advises healthcare staffing shortages from patient-facing roles to technical positions is a real concern. Burnout among healthcare workers was at a crisis level before the pandemic, and two years of dealing with COVID-19 drove burnout rates even higher. A global report reveals 47% of healthcare workers plan to leave the field by 2025. Read on to learn more.

The Advantages of Endoluminal Robotic Surgery

The Advantages of Endoluminal Robotic Surgery By Dr. Todd Wilson Chief Medical Officer EndoQuest Robotics

While robotic endoluminal surgery has many clear advantages, a key goal and a considerable challenge has been the ability to access a target location in the body with all the surgical instruments necessary to perform a procedure. For example, as seen with intraluminal surgery, endoscopists may use a colonoscope or an esophagogastroduodenoscopy (EGD) scope to perform therapeutic interventions, but treatment can be limited due to available technology that requires them to perform procedures using only one very specialized instrument at a time. Read on.

FDA Medical Device Updates

Market Reports

Executives

Advancements In Imaging

Hospitals In the News

Non-Profit News

Healthcare: Understanding the Business Side of the Industry and Its Implications

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.